TITLE

Streptococcus mutans: a rare cause of retroperitoneal abscess

AUTHOR(S)
Ioannidis, O.; Kakoutis, E.; Katsifa, H.; Rafail, S.; Chatzopoulos, S.; Kotronis, A.; Makrantonakis, N.
PUB. DATE
June 2011
SOURCE
Advances in Medical Sciences (De Gruyter Open);2011, Vol. 56 Issue 1, p113
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Retroperitoneal abscesses are uncommonly encountered clinical entities and they represent serious surgical infections associated with significant mortality rates because of their insidious clinical manifestations and diagnostic difficulty. The source of retroperitoneal infections is usually an organ contained within or abutting the retroperitoneum, usually the kidney and the microorganisms most commonly isolated are gram-negative bacilli. Gram-positive cocci, mainly staphylococcal species and rarely streptococcal species, are a less common cause of retroperitoneal abscess and are usually isolated in cases of hematogenous spread. Treatment of retroperitoneal abscesses includes identification and treatment of underlying conditions, intravenous antibiotics and adequate surgical drainage of all well-defined collections. We present a rare case of retroperitoneal abscess caused by monomicrobial Streprococcus mutans infection and discuss the possible pathogenesis, clinical presentation, diagnosis and treatment.
ACCESSION #
61031859

 

Related Articles

  • Need for new drugs to tackle 'superbugs'.  // PharmaWatch: Monthly Review;Jul2007, Vol. 6 Issue 7, p30 

    The article focuses on the need of a new antibacterial drug to treat the emerging multiple-drug resistance (MDR) gram-negative organisms. It is stated that the antibacterials available are only targeting gram-positive organism such as the methicillin resistant staphylococcus aureus (MRSA)....

  • Bad bugs, need drugs. Mardani, Masoud // Iranian Journal of Clinical Infectious Diseases;Winter2010, Vol. 5 Issue 1, p1 

    The author reflects on the world health threats including the increasing multi-antibacterial drug-resistant infections and its treatments. He presents the two recent reports from IDSA and European Centre for Disease Prevention and Control (EDCD) and the European Medicine Agency (EMEA). He says...

  • Gram-positive and gram-negative bacterial toxins in sepsis A brief review. Ramachandran, Girish // Virulence;Jan2014, Vol. 5 Issue 1, p196 

    Bacterial sepsis is a major cause of fatality worldwide. Sepsis is a multi-step process that involves an uncontrolled inflammatory response by the host cells that may result in multi organ failure and death. Both gram-negative and gram-positive bacteria play a major role in causing sepsis. These...

  • Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. Charles, Pierre Emmanuel; Ladoire, Sylvain; Aho, Serge; Quenot, Jean-Pierre; Doise, Jean-Marc; Prin, Sébastien; Olsson, Niels-Olivier; Blettery, Bernard // BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1 

    Background: In the ICU, bacteremia is a life-threatening infection whose prognosis is highly dependent on early recognition and treatment with appropriate antibiotics. Procalcitonin levels have been shown to distinguish between bacteremia and noninfectious inflammatory states accurately and...

  • ANTIMICROBIAL SUSCEPTIBILITY TESTING OF NEWER QUINOLONES AGAINST GRAM POSITIVE AND GRAM NEGATIVE CLINICAL ISOLATES. Wajiha Ifaat; Muhammad Harris Shoaib; Iyad Naeem Muhammad; Rehana; Samiah Tasleem; Shahnaz Gauhar // Pakistan Journal of Pharmaceutical Sciences;Jun2010, Vol. 23, p245 

    Antibiotic resistance development is an ongoing process associated with irrational antibiotic use. WHO recommends regular surveillance programs for monitoring of antibiotic resistance. The present study is a step in this direction. A total of 124 clinical isolates of Escherichia coli,...

  • Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Brodská, Helena; Malíčková, Karin; Adámková, Václava; Benáková, Hana; Šťastná, Markéta; Zima, Tomáš // Clinical & Experimental Medicine;Aug2013, Vol. 13 Issue 3, p165 

    Procalcitonin (PCT) levels can distinguish between infectious and non-infectious systemic inflammatory response. However, there are some differences between Gram-negative (G−), Gram-positive (G+), and fungal bloodstream infections, particularly in different cytokine profiles, severity and...

  • Aerobic Bacterial Infections in Captive Juvenile Green Turtles (Chelonia mydas) and Hawksbill Turtles (Eretmochelys imbricata) from Thailand. Chuen-Im, Thanaporn; Areekijseree, Mayuva; Chongthammakun, Sukumal; Graham, Sheila V. // Chelonian Conservation & Biology;Jun2010, Vol. 9 Issue 1, p135 

    Investigation of the total of 53 juvenile sea turtles (30 green turtles and 23 hawksbill turtles) found signs of several clinical diseases. Ultrastructure and histological observation of these tissues revealed that they were infected with one type of yeast and numerous bacteria. Using aerobic...

  • Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study. Rossolini, Gian M.; Dryden, Matthew S.; Kozlov, Roman S.; Quintana, Alvaro; Flamm, Robert K.; Läuffer, Jörg M.; Lee, Emma; Morrissey, Ian // Journal of Antimicrobial Chemotherapy (JAC);Jan2011, Vol. 66 Issue 1, p151 

    Objectives To assess the in vitro activity of ceftobiprole and comparators against a recent collection of Gram-positive and Gram-negative pathogens, in order to detect potential changes in susceptibility patterns, and to evaluate the Etest assay for ceftobiprole susceptibility testing. Methods...

  • Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. Kastoris, Antonia; Rafailidis, Petros; Vouloumanou, Evridiki; Gkegkes, Ioannis; Falagas, Matthew // European Journal of Clinical Pharmacology;Apr2010, Vol. 66 Issue 4, p359 

    The alarming increase in drug resistance and decreased production of new antibiotics necessitate the evaluation of combinations of existing antibiotics. Fosfomycin shows no cross-resistance to other antibiotic classes. Thus, its combination with other antibiotics may potentially show synergy...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics